136
Participants
Start Date
August 31, 2010
Primary Completion Date
November 30, 2012
Study Completion Date
November 30, 2012
tasimelteon
20 mg tasimelteon capsules, PO daily for 6 months
Placebo
Placebo capsules, PO daily for 6 months
New York Eye and Ear Infirmary, New York
Advanced Sleep Research GmbH, Berlin
Consolidated Clinical trials, Pittsburgh
Center For Sleep Medicine at Chestnut Hill Hospital, Philadelphia
The Center for Sleep and Wake Disorders (Washington, D.C. Metropolitan Area), Chevy Chase
SleepMed, Inc. - Columbia, Columbia
Klinische-Forschung Hannover Mitte, Hanover
Sleep Disorders Center Of Georgia, Atlanta
Ocean Sleep Disorders Center - Ormond Beach, Ormond Beach
Kendall South Medical Center, Inc., Miami
PAB Clinical Research Inc., Brandon
Universitaetsklinikum Glesen and Marburg gmbH/Schlaflabor - Sleep Lab University Marburg, Marburg
Ohio Sleep Medicine Institute (Columbus Metropolitan Area), Dublin
Bergmannsheil University Hospital - Medical Clinic III, Bochum
Tri-State Sleep Disorders Center, Cincinnati
Michigan Head-Pain Neurological Institute, Ann Arbor
Suburban Lung Associates SC (Chicago Metropolitan Area), Elk Grove Village
St. Luke's Sleep Medicine and Research Center (St. Louis Metropolitan Area), Chesterfield
Lynn Health Science Institute, Oklahoma City
Todd J. Swick, M.D., P.A., Houston
Radiant Research - Denver, Denver
Bonomed Studiezentrum, Munich
Pulmonary Associates, PA, Phoenix
St. Johns Sleep Disorder Center - St. Johns Medical Plaza, Santa Monica
SDS Clinical Trials Inc., Orange
VA Palo Alto Health Care System/PAIRE (San Fransisco Bay Area), Palo Alto
Columbia Research Group Inc., Portland
Brigham and Women's Hospital, Boston
Lead Sponsor
Vanda Pharmaceuticals
INDUSTRY